Unlocking the Mystery of Drug Development & Drug Pricing

Are you interested in getting a high level overview of the therapeutic drug/device development process? Do you want to learn more about the strategic and data considerations and regulatory oversight process associated with drug/device approvals? Do you want to understand how companies secure reimbursement and enable access to medicines? Join us on National STEM/STEAM Day for this informative seminar and discussion as we learn from experienced panelists about how new prescription drugs are discovered, tested, approved, and sold. This panel discussion will be moderated by Meena Subramanyam, Vice President and Global Program Leader in Takeda Oncology.

Panelists include:
 - Hani Houshyar, Vice President, Head of Pipeline Product Development and Commercialization at Biogen
 - Elizabeth Mulkey, FDA/Life Sciences Associate at Goodwin
 - Ipek Ozer Stillman, Head, Global Health Economics, Payer Value & Patient Access at Takeda
 - Olivia Piccione, Principal at ClearView Healthcare Partners
 - Cristiane Silva, Global GI Lead – Early Assets, Global Pricing and Access at Takeda Pharmaceuticals

Date and Time: 
November 8, 2021
6:15-7:45 PM EST


Free, subsidized by the WEST Board to bring this important information to everyone.

Given our mission is to promote women's development in STEM we would like to offer a free spot in our workshops to those in transition between jobs or who cannot afford the ticket price. Please contact [email protected] if you qualify.


Register Here